News

Date:
Introduction Many promising therapeutic compounds suffer from disadvantages such as low bioavailability, rapid clearance, and high systemic toxicity. To overcome these challenges, nanoparticles such as polymersomes can be used as promising drug delivery systems. Polymersomes are vesicles formed by…
Date:
Business Wire: May 31, 2017 – RAVENSBURG, Germany, and VANCOUVER, BC, Canada – Vetter, a leading and innovative provider of aseptic prefilled drug delivery systems, and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow, metal microneedle drug and vaccine delivery…
Date:
Business Wire: May 29, 2017 – ISSOIRE, France – BIOCORP (FR0012788065 – ALCOR/PEA‐PME eligible), a French company specializing in the development and manufacturing of medical devices and smart-drug delivery systems, announced today the signature of an industrialization contract with Virbac, the 7th…
Date:
Business Wire: May 24, 2017 – RESEARCH TRIANGLE PARK, NC, U.S.A. – Liquidia Technologies, Inc., today announced initial data from its LIQ865 internal clinical development program, which is a PRINT® formulation for the sustained-delivery of free base bupivacaine for postsurgical pain relief. The…
Date:
Business Wire: May 24, 2017 – PARIS, France, and CAMBRIDGE, MA, U.S.A. – Lysogene (Paris: LYS) (FR0013233475 – LYS), a leading, biopharmaceutical company pioneering gene therapy technologies to treat central nervous system diseases, today announced that it has entered into a strategic manufacturing…
Date:
Business Wire: May 18, 2017 – LOUGHBOROUGH, England – Results of recent clinical trials carried out on type 1 diabetics by Nemaura Pharma using its Memspatch insulin micro-needle device (IMD) will come as a relief to those who fear needles and injections, a condition medically known as…